Analysts who follow Chembio Diagnostics Inc (CEMI) on average expect it to climb 32.74% over the next twelve months. Those same analysts give the stock an average rating of Sell.
That average rating earns Chembio Diagnostics Inc an Analyst Ranking of 6, which means it ranks higher than 6 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Chembio Diagnostics Inc Stock Today?
Chembio Diagnostics Inc (CEMI) stock is higher by 8.39% while the S&P 500 is unchanged 0% as of 10:58 AM on Friday, Sep 25. CEMI has gained $0.35 from the previous closing price of $4.17 on volume of 935,962 shares. Over the past year the S&P 500 has risen 9.03% while CEMI is lower by -35.70%. CEMI lost -$1.16 per share the over the last 12 months.
Click Here to get the full report on Chembio Diagnostics Inc (CEMI) Stock.
